Bank of America
XBIO icon

Bank of America’s Xenetic Biosciences XBIO Stock Holding History

Bank of America’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18
Closed -$39 – 6926
2025
Q4 		$39 Buy
18
+6
+50% +$19 ﹤0.01% 7001
2025
Q3 		$38 Sell
12
-1
-8% -$3 ﹤0.01% 8071
2025
Q2 		$51 Buy
13
+2
+18% +$6 ﹤0.01% 8101
2025
Q1 		$29 Hold
11
– – ﹤0.01% 8068
2024
Q4 		$44 Sell
11
-18
-62% -$73 ﹤0.01% 7884
2024
Q3 		$126 Buy
29
+18
+164% +$71 ﹤0.01% 7672
2024
Q2 		$45 Buy
+11
New +$44 ﹤0.01% 7860
2021
Q4 		– Sell
-10
Closed – – 8685
2021
Q3 		$0 Buy
10
+1
+11% +$27 ﹤0.01% 8430
2021
Q2 		$0 Buy
+9
New +$182 ﹤0.01% 8131
2019
Q1 		– Hold
0
– – – 7439
2018
Q4 		– Sell
-1
Closed -$303 – 7415
2018
Q3 		$0 Buy
+1
New +$390 ﹤0.01% 7499
2018
Q2 		– Hold
0
– – – 7356
2017
Q2 		– Hold
0
– – – 7199
2017
Q1 		– Hold
0
– – – 7272
2016
Q4 		– Hold
0
– – – 7350

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
DWM
Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

Bank of America's XBIO Position: Q1 2026 in Review

Bank of America sold out of Xenetic Biosciences (XBIO) in Q1 2026, closing a stake of 18 shares — an estimated $39 sold.

Bank of America first reported a position in XBIO in Q3 2018 and held it in 10 quarters. The position peaked at $126 in Q3 2024. 6 funds tracked by Wall St. Rank hold XBIO as of Q1 2026.

  • Bank of America reported no remaining Xenetic Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 18 Xenetic Biosciences shares in Q1 2026, an estimated $39.
  • Bank of America first reported a position in Xenetic Biosciences in Q3 2018 and held it in 10 quarters.
  • Bank of America's Xenetic Biosciences position peaked at $126 in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.